BEARSDEN BIO INC has a total of 21 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are HOFFMANN LA ROCHE CO LTD, ABBOTT LAB and MITOKOR.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Canada | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Maccecchini Maria-Luisa | 5 |
#2 | Giordano Tony | 5 |
#3 | Beach Deborah L | 4 |
#4 | Gu Zi-Qiang | 3 |
#5 | Pelletier Jeffrey C | 3 |
#6 | Collins Mark A | 3 |
#7 | Sturgess Michael | 3 |
#8 | Hesson David Paul | 2 |
#9 | Sturgess Michael Alan | 2 |
#10 | Jacobs David | 1 |
Publication | Filing date | Title |
---|---|---|
CA2282357A1 | Method of determining protein-ligand interactions via computer modeling | |
CA2262920A1 | Method for identifying compounds affecting rna/rna binding protein interactions | |
US5859227A | RNA sequences which interact with RNA-binding proteins | |
CA2222316A1 | Dihydrophthalazine antagonists of excitatory amino acid receptors | |
CA2216648A1 | Alkylcarboxy amino acids-modulators of the kainate receptor | |
US6048853A | 1-arylphthalazine antagonists of excitatory amino acid receptors | |
US5854217A | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |